Cytochrome P4501A1 polymorphisms in South American Indians

Area of Science:

• Genetics
• Population Genetics
• Pharmacogenomics

Background:

• The CYP1A1 gene plays a crucial role in metabolizing various xenobiotics, including environmental toxins and drugs.
• Polymorphisms in CYP1A1 can influence individual susceptibility to diseases and drug response.
• Understanding the genetic diversity of CYP1A1 in Indigenous populations is vital for public health and personalized medicine.

Purpose of the Study:

• To investigate the frequency and distribution of two specific CYP1A1 gene polymorphisms (*val at codon 462 and MspI *m2 at T6235C) in five Brazilian Indigenous tribes.
• To determine the haplotype distribution of these polymorphisms within and among the studied populations.
• To compare the observed frequencies with global data.

Main Methods:

• Genotyping of 131 individuals from five Brazilian Indigenous tribes.
• Analysis of two CYP1A1 gene polymorphisms: *val allele at codon 462 and MspI restriction site (*m2 allele) at T6235C.
• Haplotype analysis to determine combined genotypes.

Main Results:

• Significant variation in the *val allele frequency (54%-97%) and *m2 allele frequency (72%-95%) was observed across the five tribes.
• Haplotype analysis revealed a highly heterogeneous distribution among the populations.
• The *val/*m2 haplotype was the most common, ranging from 54% to 94%, representing the highest prevalence reported worldwide.

Conclusions:

• Brazilian Indigenous populations exhibit significant genetic diversity in CYP1A1 polymorphisms.
• The exceptionally high prevalence of the *val/*m2 haplotype in these populations suggests a unique evolutionary history or selective pressures.
• These findings have implications for understanding disease risk and drug metabolism in South Amerindian populations.